Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 132

    1.

    Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study.

    Worm SW, Sabin CA, Reiss P, El-Sadr W, Monforte A, Pradier C, Thiebaut R, Law M, Rickenbach M, De Wit S, Lundgren JD, Friis-Møller N.

    Diabetes Care. 2009 Mar;32(3):474-80. Epub 2008 Dec 3.PMID: 19056612 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction.

    Data Collection on Adverse Events of Anti-HIV Drugs Study Group, Sabin CA, d'Arminio Monforte A, Friis-Moller N, Weber R, El-Sadr WM, Reiss P, Kirk O, Mercie P, Law MG, De Wit S, Pradier C, Phillips AN, Lundgren JD.

    Clin Infect Dis. 2008 Apr 1;46(7):1101-10.PMID: 18461712 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.

    Friis-Møller N, Weber R, Reiss P, Thiébaut R, Kirk O, d'Arminio Monforte A, Pradier C, Morfeldt L, Mateu S, Law M, El-Sadr W, De Wit S, Sabin CA, Phillips AN, Lundgren JD; DAD study group.

    AIDS. 2003 May 23;17(8):1179-93.PMID: 12819520 [PubMed - indexed for MEDLINE]Related articles

    4.

    The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study.

    Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Gemma L, Santi L, Bonadonna RC, Muggeo M.

    Diabet Med. 2004 Jan;21(1):52-8.PMID: 14706054 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

    Scott R, O'Brien R, Fulcher G, Pardy C, D'Emden M, Tse D, Taskinen MR, Ehnholm C, Keech A; Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study Investigators.

    Diabetes Care. 2009 Mar;32(3):493-8. Epub 2008 Nov 4.PMID: 18984774 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection.

    Wand H, Calmy A, Carey DL, Samaras K, Carr A, Law MG, Cooper DA, Emery S; INITIO Trial International Coordinating Committee.

    AIDS. 2007 Nov 30;21(18):2445-53.PMID: 18025881 [PubMed - indexed for MEDLINE]Related articles

    8.

    Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

    De Wit S, Sabin CA, Weber R, Worm SW, Reiss P, Cazanave C, El-Sadr W, Monforte A, Fontas E, Law MG, Friis-Møller N, Phillips A; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

    Diabetes Care. 2008 Jun;31(6):1224-9. Epub 2008 Feb 11.PMID: 18268071 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Implications for syndrome X.

    Gaillard TR, Schuster DP, Bossetti BM, Green PA, Osei K.

    Diabetes Care. 1997 May;20(5):745-52.PMID: 9135936 [PubMed - indexed for MEDLINE]Related articles

    10.

    Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population.

    Mondy K, Overton ET, Grubb J, Tong S, Seyfried W, Powderly W, Yarasheski K.

    Clin Infect Dis. 2007 Mar 1;44(5):726-34. Epub 2007 Jan 22.PMID: 17278068 [PubMed - indexed for MEDLINE]Related articles

    12.

    Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).

    Worm SW, De Wit S, Weber R, Sabin CA, Reiss P, El-Sadr W, Monforte AD, Kirk O, Fontas E, Dabis F, Law MG, Lundgren JD, Friis-Møller N.

    Circulation. 2009 Feb 17;119(6):805-11. Epub 2009 Feb 2.PMID: 19188509 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Incidence of metabolic syndrome in a cohort of HIV-infected adults and prevalence relative to the US population (National Health and Nutrition Examination Survey).

    Jacobson DL, Tang AM, Spiegelman D, Thomas AM, Skinner S, Gorbach SL, Wanke C.

    J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):458-66.PMID: 16980905 [PubMed - indexed for MEDLINE]Related articles

    14.

    Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?

    Stern MP, Williams K, González-Villalpando C, Hunt KJ, Haffner SM.

    Diabetes Care. 2004 Nov;27(11):2676-81. Erratum in: Diabetes Care. 2005 Jan;28(1):238. PMID: 15505004 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.

    Masiá M, Padilla S, Bernal E, Almenar MV, Molina J, Hernández I, Graells ML, Gutiérrez F.

    Clin Ther. 2007 Jul;29(7):1448-55.PMID: 17825696 [PubMed - indexed for MEDLINE]Related articles

    17.

    Dyslipidemic hypertension: distinctive features and cardiovascular risk in a prospective population-based study.

    Onat A, Hergenç G, Sari I, Türkmen S, Can G, Sansoy V.

    Am J Hypertens. 2005 Mar;18(3):409-16.PMID: 15797662 [PubMed - indexed for MEDLINE]Related articles

    18.

    Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).

    Cheung BM, Wat NM, Man YB, Tam S, Cheng CH, Leung GM, Woo J, Janus ED, Lau CP, Lam TH, Lam KS.

    Am J Hypertens. 2008 Jan;21(1):17-22.PMID: 18091739 [PubMed - indexed for MEDLINE]Related articles

    19.

    A high risk score for coronary heart disease is associated with the metabolic syndrome in 40-year-old men and women.

    Tonstad S, Hjermann I.

    J Cardiovasc Risk. 2003 Apr;10(2):129-35.PMID: 12668910 [PubMed - indexed for MEDLINE]Related articles

    20.

    Metabolic syndrome and diabetes, alone and in combination, as predictors of cardiovascular disease mortality among men.

    Church TS, Thompson AM, Katzmarzyk PT, Sui X, Johannsen N, Earnest CP, Blair SN.

    Diabetes Care. 2009 Jul;32(7):1289-94. Epub 2009 Apr 14.PMID: 19366967 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data